Name of notified body
Notified body number
Country
Sent by
Contact person
Telephone
Fax
Client reference (name of manufacturer and, if applicable, of authorised representative)
Confirmation that, in accordance with Article 11 of Directive 90/385/EEC and Article 16 of Directive 93/42/EEC, respectively, and Article 4 of Regulation (EU) No 722/2012, the submitting notified body has been designated by its competent authority for the conformity assessment of
active implantable medical devices manufactured utilising tissues of animal origin subject to Regulation (EU) No 722/2012,
medical devices manufactured utilising tissues of animal origin subject to Regulation (EU) No 722/2012
(a) Active implantable medical device Other medical device
(b) Product description and composition
Information on intended use
(a) EDQM certificate available YES NO
(If the EDQM certificate is available, it must be submitted with this summary evaluation report.)
(b) Information regarding
the nature of the starting tissue(s):
animal species(s):
geographical source(s):
A description of the key elements adopted to minimise the risk of infection:
An estimate of the TSE risk arising from the use of the product, taking into account the likelihood of contamination of the product, the nature and duration of patient exposure:
A justification for the use of animal tissues or derivatives in the medical device, including a rationale for the acceptability of the overall TSE risk estimate, the evaluation of alternative materials and the expected clinical benefit:
The approach to the auditing of source establishments and suppliers for the animal material used by the device manufacturer:
Conclusion of this assessment:
Based on the evaluation of data and the assessment process it is our preliminary decision that the application meets the requirements of conformity with
Council Directive 90/385/EEC Council Directive 93/42/EEC
and Regulation (EU) No 722/2012.
This report was sent on … to the Coordinating Competent Authority of … to inform the Competent Authorities of the other Member States and the Commission and to seek their comments, if any.